Heartflow (HTFL) Asset Utilization Ratio (2025 - 2026)
Heartflow (HTFL) posted Asset Utilization Ratio of 0.58 for Q2 2026, up 20.05% on a QoQ basis from 0.48 in Q4 2025, and down 43.71% year-over-year from 1.02 in Q2 2025.
Powered by 
Analysis
Heartflow (HTFL) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Heartflow has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.58 in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 43.71% year-over-year to 0.58 in Q2 2026; TTM through Jun 2026 was 0.58, a 43.71% decrease from a year earlier, with the FY2025 full-year figure at 0.74, changed N/A from the prior year.
- Asset Utilization Ratio was 0.58 for Q2 2026 at Heartflow, up from 0.48 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.02 in Q2 2025, with the low at 0.48 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 0.57 |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 0.65 |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | 0.58 |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 0.26 |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 0.39 |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 0.59 |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 0.79 |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | 0.85 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.58 |
| Dec 31, 2025 | 0.48 |
| Sep 30, 2025 | 0.60 |
| Jun 30, 2025 | 1.02 |